Review: Methylene Blue cheapest Covid-19 Treatment
Article Information
Publication Timeline
- Received05 May 2021
- Accepted21 May 2021
Abstract
Covid- 19 contamination normally starts within the breathing tract in which it could reason bilateral pneumonia. The disorder can evolve into acute respiratory syndrome and multi-organ failure; because of viral expand within the blood and an immoderate inflammatory response together with cytokine storm. Antiviral and anti-cytokine tablets have validated to be poorly or in-powerful in preventing disorder progression, and mortality. Persistent efficacy of antiviral tablets might be because of overdue administration, whilst the virus has brought about the inflammatory response and is now not the primary protagonist. We propose in this review article that Methylene Blue could be a therapy option for Corona Virus Disease in 2019 especially in patients with mild or moderate symptom. We found that methylene blue; a tricyclic phenothiazine compound permitted through the FDA for the remedy of methemoglobinemia and used for different clinical applications inhibits this interaction. It inhibited the access of a SARS-CoV-2 spike bearing pseudovirus into ACE2-expressing cells with comparable IC50 value. Hence, its antiviral activity in opposition to SARS-CoV-2 may want to make a contribution in making less expensive and broadly to be had drug doubtlessly beneficial within the prevention and remedy of COVID-19 as an oral or inhaled medication.
References
- Scigliano G, Scigliano GA. Methylene blue in covid-19. Medical Hypotheses. 2021; 146:110455. [Google Scholar][Crossref]
- Alamdari Daryoush Hamidi, et al. Application of methylene blue-vitamin C–N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial. European journal of pharmacology. 2020; 885:173494. [Google Scholar][Crossref]
- Gendrot Mathieu, et al. Methylene blue inhibits replication of SARS-CoV-2 in vitro. International Journal of Antimicrobial Agents. 2020; 56.6:106202. [Google Scholar][Crossref]
- JIN Changzhong, et al. Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19. BMC Infectious Diseases. 2021; 21.1:1-8. [Google Scholar][Crossref]
- Porat Rachel, Gilbert Steve. Magilner David. Methylene blue-induced phototoxicity: an unrecognized complication. Pediatrics. 1996; 97.5:717-721. [Google Scholar][Crossref]
- Svyatchenko VA, Nikonov SD, Mayorov AP, Gelfond ML, Loktev VB. Antiviral photodynamic therapy: Inactivation and inhibition of SARS-CoV-2 in vitro using methylene blue and Radachlorin. Photodiagnosis and Photodynamic Therapy. 2021; 33:102112. [Google Scholar][Crossref]
- Alamdari DH, Moghaddam AB, Amini S, Keramati MR, Zarmehri AM, Alamdari AH, et al. Application of methylene blue-vitamin C–N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial. European journal of pharmacology. 2020; 885:173494. [Google Scholar][Crossref]
- Ghahestani SM, Shahab E, Karimi S, Madani MH. Methylene blue may have a role in the treatment of COVID-19. Medical Hypotheses. 2020; 144:110163. [Google Scholar][Crossref]
How to Cite
Soni, A., Gupta, S., & Gupta, A. K. (2021). Review: Methylene Blue cheapest Covid-19 Treatment. International Journal of Medical and All Body Health Research, 2(2), 16-18.
Soni, Anjali, et al. "Review: Methylene Blue cheapest Covid-19 Treatment." International Journal of Medical and All Body Health Research, vol. 2, no. 2, 2021, pp. 16-18.
Soni, A., Gupta, S. and Gupta, A. K. (2021) 'Review: Methylene Blue cheapest Covid-19 Treatment', International Journal of Medical and All Body Health Research, 2(2), pp. 16-18.
Soni A, Gupta S, Gupta AK. Review: Methylene Blue cheapest Covid-19 Treatment. International Journal of Medical and All Body Health Research. 2021;2(2):16-18.
Similar Articles
- Are gastrointestinal manifestations related to SARS-CoV-2 during the COVID-19 pandemic in patients referring to the emergency ward? Vol 1, Issue 4 (2020)
- Mathematical model analysis of covid-19 (SARS-Cov-2) using compartmental models in epidemiology and ethical practices to break the chain of infection Vol 1, Issue 4 (2020)
- King Salman Specialist Hospital study for use of hydroxychloroquine in COVID 19 positive patients at Hail region, and relation with cardiovascular risk factors Vol 1, Issue 2 (2020)
- Determination of twenty chemical element contents in macro-and micro-follicular colloid goiter using neutron activation analysis and inductively coupled plasma atomic emission spectrometry Vol 2, Issue 2 (2021)
- Factors influencing health care utilization in rural women of Bangladesh Vol 2, Issue 2 (2021)
Find this Article on
Google Scholar Semantic Scholar OpenAlex ResearchGate BASEA newly published article may take a few days to appear on these services.